Pricing

Achilles Therapeutics PLC (ACHL)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Iraj Ali
Employees:
250
245 HAMMERSMITH ROAD, LONDON, X0, W6 8PW
44 (0)20 8154 4600
Achilles Therapeutics Plc develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; THETIS, a product candidate in clinical trials for use of metastatic or recurrent melanoma. Achilles is headquartered in London, the United Kingdom.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available